Skip to main content
Clinical Trials/NCT03975218
NCT03975218
Completed
N/A

Involvement of the Physician in Primary Prevention and Pre-hospital Management of Stroke

Fondation Hôpital Saint-Joseph1 site in 1 country18 target enrollmentJune 7, 2019
ConditionsStroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke
Sponsor
Fondation Hôpital Saint-Joseph
Enrollment
18
Locations
1
Primary Endpoint
Time until patient's care in the hospital after stroke's symptoms
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Stroke is a growing disease. It is the first pathology responsible for acquired handicap, the second of dementia and the second cause of death in the world. In France, they are the leading cause of death in women and the third cause in men. Sequelae and disabilities also represent a significant financial cost for health insurance.

The early management of the treatment improves the patient's vital and functional prognosis. The ability of the patient to identify the signs of stroke requiring urgent consultation and proper orientation are therefore crucial for further management.

The most common signs that patients must recognize are muscle weakness or sudden paralysis of an arm, leg or half of the body, asymmetry of the face, tingling, numbness of a hemi-body, speech or understanding, loss of vision of an eye or hemifield, disorder of the coordination of a hemi-body. The variety of clinical pictures complicates primary prevention.

In this context, a 2010-2014 National Stroke Action Plan was undertaken with the aim, among other things, of developing information to prevent stroke and to limit its sequelae. In this plan, the attending physician must improve prevention in high-risk patients and be a link between the city and the hospital for follow-up.

Several questions arise:

  • Are patients who are regularly followed by a general practitioner better educated on the signs of stroke / TIA and thus more able to give an appropriate warning?
  • What is the profile of patients who have not been affected by the different modes of primary prevention?
  • What are the effective means of information and those desired
Registry
clinicaltrials.gov
Start Date
June 7, 2019
End Date
December 5, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient whose age is ≥ 18 years
  • Patient hospitalized in the neurology / neurovascular department within the GHPSJ following a stroke (first episode or recurrence)
  • Francophone patient

Exclusion Criteria

  • Patient with previously labeled cognitive impairment
  • Patient under tutorship or curatorship
  • Patient deprived of liberty
  • Patient unable to answer the questionnaire
  • Patient opposing participation in the study

Outcomes

Primary Outcomes

Time until patient's care in the hospital after stroke's symptoms

Time Frame: Day 1

The delay between the observation of signs of stroke and specialized neurovascular management at the hospital will be measured. This measures the impact of physician's prevention on the management of stroke.

Secondary Outcomes

  • Study the different effective means of primary prevention(Day 1)

Study Sites (1)

Loading locations...

Similar Trials